Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896668644> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W2896668644 endingPage "901" @default.
- W2896668644 startingPage "893" @default.
- W2896668644 abstract "Objective: This retrospective database analysis complements previous research to understand treatment patterns for German patients newly-initiating or switching to subsequent GLP-1 RAs.Methods: Adult patients (≥18 years) initiating GLP-1 RA (Cohort 1 [C1]) or switching from a previous GLP-1 RA (Cohort 2 [C2]) to exenatide twice-daily (exBID), exenatide once-weekly (exQW), dulaglutide (DULA), or liraglutide (LIRA) were included in this analysis using IQVIA LRx from January 1, 2014–March 31, 2017. Patients were required to have ≥1 oral anti-hyperglycemic prescription during the 6-month pre-index period and ≥12 months follow-up. Persistence and treatment modifications were assessed within and beyond 12 months follow-up. Average daily/weekly dosage (ADD/AWD) was calculated during persistence.Results: C1 included 13,417 patients, while C2 included 4,264 patients. Mean ± standard deviation (SD) age was similar (57.7 ± 11.1 years [C1], 58.9 ± 10.1 years [C2]). Most patients using DULA in C2 had switched from LIRA (56.6%). For C1, mean ADD for LIRA was 1.41 ± 0.10 mg, slightly higher in C2, and increased over time. ADD for exBID was 16.9 ± 1.0 mcg, slightly greater in C2. AWD was 2.00 ± 0.05 mg for exQW users and 1.42 ± 0.03 mg for DULA users in C1, similar to C2. For C1, 27.0% exBID, 35.3% exQW, 50.9% DULA, and 48.1% LIRA users remained persistent at 12 months. Patients using DULA had a higher probability of remaining persistent over time (Kaplan-Meier) for both cohorts.Conclusions: Patients using DULA had the highest probability of remaining persistent over time, followed by LIRA. ADD/AWD for DULA, exQW, and exBID were aligned with the recommended combination therapy dose; LIRA ADD suggests some patients use the 1.8 mg dose." @default.
- W2896668644 created "2018-10-26" @default.
- W2896668644 creator A5065995887 @default.
- W2896668644 creator A5070145722 @default.
- W2896668644 creator A5077195561 @default.
- W2896668644 creator A5078047344 @default.
- W2896668644 creator A5085539548 @default.
- W2896668644 creator A5086013759 @default.
- W2896668644 date "2018-11-14" @default.
- W2896668644 modified "2023-09-27" @default.
- W2896668644 title "Utilization patterns of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus in Germany: a retrospective cohort study" @default.
- W2896668644 cites W1885494502 @default.
- W2896668644 cites W2002757015 @default.
- W2896668644 cites W2036845531 @default.
- W2896668644 cites W2059909265 @default.
- W2896668644 cites W2075474921 @default.
- W2896668644 cites W2090953432 @default.
- W2896668644 cites W2108751089 @default.
- W2896668644 cites W2120779228 @default.
- W2896668644 cites W2137106767 @default.
- W2896668644 cites W2171233776 @default.
- W2896668644 cites W2194838818 @default.
- W2896668644 cites W2333363363 @default.
- W2896668644 cites W2401934785 @default.
- W2896668644 cites W2562313990 @default.
- W2896668644 cites W2570638938 @default.
- W2896668644 cites W2586129535 @default.
- W2896668644 cites W2588741033 @default.
- W2896668644 cites W2604623769 @default.
- W2896668644 cites W4214911496 @default.
- W2896668644 cites W4232754143 @default.
- W2896668644 doi "https://doi.org/10.1080/03007995.2018.1538011" @default.
- W2896668644 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30328731" @default.
- W2896668644 hasPublicationYear "2018" @default.
- W2896668644 type Work @default.
- W2896668644 sameAs 2896668644 @default.
- W2896668644 citedByCount "16" @default.
- W2896668644 countsByYear W28966686442019 @default.
- W2896668644 countsByYear W28966686442020 @default.
- W2896668644 countsByYear W28966686442021 @default.
- W2896668644 countsByYear W28966686442023 @default.
- W2896668644 crossrefType "journal-article" @default.
- W2896668644 hasAuthorship W2896668644A5065995887 @default.
- W2896668644 hasAuthorship W2896668644A5070145722 @default.
- W2896668644 hasAuthorship W2896668644A5077195561 @default.
- W2896668644 hasAuthorship W2896668644A5078047344 @default.
- W2896668644 hasAuthorship W2896668644A5085539548 @default.
- W2896668644 hasAuthorship W2896668644A5086013759 @default.
- W2896668644 hasBestOaLocation W28966686441 @default.
- W2896668644 hasConcept C126322002 @default.
- W2896668644 hasConcept C134018914 @default.
- W2896668644 hasConcept C167135981 @default.
- W2896668644 hasConcept C2777180221 @default.
- W2896668644 hasConcept C2779829264 @default.
- W2896668644 hasConcept C2780533449 @default.
- W2896668644 hasConcept C2781308992 @default.
- W2896668644 hasConcept C555293320 @default.
- W2896668644 hasConcept C71924100 @default.
- W2896668644 hasConcept C72563966 @default.
- W2896668644 hasConceptScore W2896668644C126322002 @default.
- W2896668644 hasConceptScore W2896668644C134018914 @default.
- W2896668644 hasConceptScore W2896668644C167135981 @default.
- W2896668644 hasConceptScore W2896668644C2777180221 @default.
- W2896668644 hasConceptScore W2896668644C2779829264 @default.
- W2896668644 hasConceptScore W2896668644C2780533449 @default.
- W2896668644 hasConceptScore W2896668644C2781308992 @default.
- W2896668644 hasConceptScore W2896668644C555293320 @default.
- W2896668644 hasConceptScore W2896668644C71924100 @default.
- W2896668644 hasConceptScore W2896668644C72563966 @default.
- W2896668644 hasFunder F4320307758 @default.
- W2896668644 hasIssue "5" @default.
- W2896668644 hasLocation W28966686441 @default.
- W2896668644 hasLocation W28966686442 @default.
- W2896668644 hasOpenAccess W2896668644 @default.
- W2896668644 hasPrimaryLocation W28966686441 @default.
- W2896668644 hasRelatedWork W2035764252 @default.
- W2896668644 hasRelatedWork W2460294411 @default.
- W2896668644 hasRelatedWork W2490399744 @default.
- W2896668644 hasRelatedWork W2592545469 @default.
- W2896668644 hasRelatedWork W2766951124 @default.
- W2896668644 hasRelatedWork W2963614034 @default.
- W2896668644 hasRelatedWork W3108353055 @default.
- W2896668644 hasRelatedWork W4232362753 @default.
- W2896668644 hasRelatedWork W4289779349 @default.
- W2896668644 hasRelatedWork W4379233206 @default.
- W2896668644 hasVolume "35" @default.
- W2896668644 isParatext "false" @default.
- W2896668644 isRetracted "false" @default.
- W2896668644 magId "2896668644" @default.
- W2896668644 workType "article" @default.